Literature DB >> 3221906

Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity.

H W Ziegler-Heitbrock1, C Thiel, J G Haas, A Möller, G Riethmüller.   

Abstract

The WEHI-164 target cells pretreated with actinomycin D can be employed in a 7-hour 51Cr release assay that exhibits exquisite susceptibility for cytotoxic monocytes without contribution by natural killer cells. The system can be used either to detect cell-mediated monocyte cytotoxicity directly or to measure cytotoxic-factor activity in cell-free supernatants. Analysis of cytotoxic factor demonstrates molecular characteristics similar to tumor necrosis factor (TNF), and polyclonal as well as monoclonal antibodies specific for TNF can readily neutralize the monocyte-generated cytotoxic factor. In the cell-mediated approach, neutralization can be achieved as well, although somewhat higher amounts of antibody are required. Hence, the WEHT-164/actinomycin D system appears to detect monocyte cytotoxicity that is mediated by TNF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3221906

Source DB:  PubMed          Journal:  Nat Immun Cell Growth Regul        ISSN: 0254-7600


  2 in total

1.  Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.

Authors:  T Valković; D Fuckar; S Stifter; K Matusan; M Hasan; F Dobrila; N Jonjić
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-10       Impact factor: 4.553

2.  Production of interleukin-1 and tumour necrosis factor in non-Hodgkin's lymphoma patients.

Authors:  K Jhaver; A De; S Advani; J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.